• Memory loss reversed or abated in those

    From ScienceDaily@1337:3/111 to All on Fri Jul 31 21:30:18 2020
    Memory loss reversed or abated in those with cognitive decline

    Date:
    July 31, 2020
    Source:
    IOS Press
    Summary:
    Researchers sought to determine whether a comprehensive and
    personalized program, designed to mitigate risk factors of
    Alzheimer's disease could improve cognitive and metabolic function
    in individuals experiencing cognitive decline. Findings provided
    evidence that this approach can improve risk factor scores and
    stabilize cognitive function.



    FULL STORY ========================================================================== Latest research from Affirmativ Health succeeds in treating cognitive
    decline using personalized, precision medicine.


    ========================================================================== Affirmativ Health sought to determine whether a comprehensive and
    personalized program, designed to mitigate risk factors of Alzheimer's
    disease could improve cognitive and metabolic function in individuals experiencing cognitive decline.

    Findings provided evidence that this approach can improve risk factor
    scores and stabilize cognitive function.

    July 31, 2020/Sonoma, CA Cognitive decline is a major concern of the
    aging population. Already, Alzheimer's disease affects approximately
    5.4 million Americans and 30 million people globally. Without effective prevention and treatment, the prospects for the future are bleak. By 2050,
    it is estimated that 160 million people globally will have the disease, including 13 million Americans, leading to potential bankruptcy of the
    Medicare system. Unlike several other chronic illnesses, Alzheimer's
    disease is on the rise -- recent estimates suggest that Alzheimer's
    disease has become the third leading cause of death in the United States
    behind cardiovascular disease and cancer. Since its first description
    over 100 years ago, Alzheimer's disease has been without effective
    treatment. While researchers continue to seek out a cure, it is becoming
    clear that there are effective treatment options. More and more research supports the conclusion that Alzheimer's disease is not a disease of only
    Beta Amyloid plaques and Tao tangles but a complex and systemic disease.

    In this study of patients with varying levels of cognitive decline,
    it is demonstrated how a precision and personalized approach results in
    either stabilization or improvement in memory.

    Interventions to stop the progression of Alzheimer's disease have been marginally successful at best. This study uses a more comprehensive, personalized approach addressing each participant's unique risk
    factors. "The findings, published in the Journal of Alzheimer's Disease
    Reports (Journal of Alzheimer's Disease Reports 4(1)), are encouraging
    and indicate that a more extensive clinical study is warranted," said
    Brian Kennedy, PhD, Director of The Centre for Healthy Aging, National University Health System, Singapore and Chief Scientific Officer,
    Affirmativ Health.

    The Affirmativ Health scientific team, after thorough review of
    published research, has developed a comprehensive approach to
    addressing scientifically supported risk factors that have been
    rigorously defined as interventions to promote prevention, increased resiliency, and stabilization of brain function in the realm of AD and dementia. Utilizing cutting edge technology in concert with in-person
    coaching and consultation, we are demonstrating that a multi- modal and personalized approach promotes an improved resiliency and restoration
    of optimal brain function. The personalized therapeutic program includes genetics, an extensive blood panel, medical history and lifestyle data to evaluate relevant metabolic risk factors and nutrient levels associated
    with cognitive health. "Target laboratory levels differ from standard laboratory ranges as the goal is to reach optimized levels for cognitive health," Ginger Schechter, MD, Chief Medical Officer, Affirmativ Health
    The study approach considers more than 35 factors known to contribute
    to cognitive decline. Results demonstrate that certain of those factors
    are more affected than others again demonstrating the need for a more
    precise treatment plan. "This study supports the need for an approach
    that focuses on a one-size fits one, not a one-size fits all, approach
    that comprehensively assesses all involved risk factors affecting
    memory loss," Denise M Kalos, CEO Affirmativ Health In conjunction
    with the publication of this vital study, and to expose alternative
    treatment options for Alzheimer's disease and cognitive decline, the
    team at Affirmativ Health has written a book, Outsmart your Brain --
    an Insider's Guide to Life-Long Memory. "Memory is not something that
    should diminish with age; you are never too young to start developing
    healthy habits that can ultimately impact your cognition," Outsmart
    Your Brain. This book leverages the foundation of Affirmativ Health's
    research to deliver a tips and tools guide for the maintenance of good cognitive health. "Far too few people understand how critical lifestyle
    and dietary choices are for brain function.

    'Outsmart Your Brain' is an important tool to get this information into
    the hands of those who should know it, everyone!, in easy-to-understand language," Ryan R. Fortna, MD, PhD, Chief Medical/Scientific Officer,
    ADx Healthcare.


    ========================================================================== Story Source: Materials provided by IOS_Press. Note: Content may be
    edited for style and length.


    ========================================================================== Journal Reference:
    1. Ginger Schechter, Gajendra Kumar Azad, Rammohan Rao, Allison
    McKeany,
    Matthew Matulaitis, Denise M. Kalos, Brian K. Kennedy. A
    Comprehensive, Multi-Modal Strategy to Mitigate Alzheimer's Disease
    Risk Factors Improves Aspects of Metabolism and Offsets Cognitive
    Decline in Individuals with Cognitive Impairment. Journal of
    Alzheimer's Disease Reports, 2020; 1 DOI: 10.3233/ADR-200185 ==========================================================================

    Link to news story: https://www.sciencedaily.com/releases/2020/07/200731104124.htm

    --- up 2 weeks, 2 days, 1 hour, 54 minutes
    * Origin: -=> Castle Rock BBS <=- Now Husky HPT Powered! (1337:3/111)